Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 3/2016

01-02-2016 | Letter to the Editor

Paraneoplastic cerebellar degeneration as an early sign of classical Hodgkin lymphoma

Authors: Julie Chepovetsky, Amy S. Duffield, Jeffrey J. Pu

Published in: Annals of Hematology | Issue 3/2016

Login to get access

Excerpt

Dear Editor, …
Literature
1.
2.
Psimaras D, Carpentier AF, Rossi C (2010) Cerebrospinal fluid study in paraneoplastic syndromes. PNS Euronetwork J Neurol Neurosurg Psychiatry 81(1):42–5CrossRefPubMed
3.
Kannoth S (2012) Paraneoplastic neurologic syndrome: a practical approach. Ann Ind Acad Neurol 15(1):6–12CrossRef
4.
Honnorat J, Cartalat-Carel S (2004) Advances in paraneoplastic neurological syndromes. Curr Opin Oncol 16(6):614–20, ReviewCrossRefPubMed
5.
Trotter JL, Hendin BA, Osterland CK (1976) Cerebellar degeneration with Hodgkin disease. An immunological study. Arch Neurol 33(9):660–1CrossRefPubMed
6.
Graus F, Gultekin SH, Ferrer I, Reiriz J, Alberch J, Dalmau J (1998) Localization of the neuronal antigen recognized by anti-Tr antibodies from patients with paraneoplastic cerebellar degeneration and Hodgkin’s disease in the rat nervous system. Acta Neuropathol 96(1):1–7CrossRefPubMed
7.
Bernal F, Shams'ili S, Rojas I, Sanchez-Valle R, Saiz A, Dalmau J et al (2003) Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin’s disease. Neurology 60:230–4CrossRefPubMed
Metadata
Title
Paraneoplastic cerebellar degeneration as an early sign of classical Hodgkin lymphoma
Authors
Julie Chepovetsky
Amy S. Duffield
Jeffrey J. Pu
Publication date
01-02-2016
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 3/2016
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-015-2542-5

Other articles of this Issue 3/2016

Annals of Hematology 3/2016 Go to the issue

Letter to the Editor

Extinction of myeloproliferative neoplasm by acquisition of a lymphoid disease: JAK2 V617F and JAK2 exon 12 allele burden disappearance during the follow-up of two patients

Letter to the Editor

Brentuximab-induced hand-foot syndrome in a Hodgkin lymphoma patient

Letter to the Editor

Immune thrombocytopenic purpurae presenting with cortical vein thrombosis: is it rebalanced hemostasis?

Letter to the Editor

Myelodysplastic syndrome with del (5q) and JAK2V617F mutation transformed to acute myeloid leukaemia with complex karyotype

Original Article

Dysregulation of ferroportin gene expression in β0-thalassemia/Hb E disease

Original Article

Refractory acute lymphoblastic leukemia in Chinese children: bridging to stem cell transplantation with clofarabine, cyclophosphamide and etoposide
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits